{"id":45490,"date":"2022-06-24T17:01:42","date_gmt":"2022-06-24T15:01:42","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/"},"modified":"2022-06-24T17:01:42","modified_gmt":"2022-06-24T15:01:42","slug":"worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/","title":{"rendered":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 &#8211; Insight, Epidemiology and Market Forecasts &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4855540\/systemic-sclerosis-associated-interstitial-lung?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=n7dczx&amp;utm_campaign=1718532+-+Worldwide+Systemic+Sclerosis-associated+Interstitial+Lung+Disease+Industry+to+2032+-+Insight%2C+Epidemiology+and+Market+Forecasts&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis report delivers an in-depth understanding of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), historical and forecasted epidemiology as well as the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.\n<\/p>\n<p>\nThe Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market report provides current treatment practices, emerging drugs, Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market share of the individual therapies, current and forecasted Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market Size from 2019 to 2032 segmented by seven major markets.\n<\/p>\n<p>\nThe Report also covers current Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.\n<\/p>\n<p>\n<strong>Geography Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>KOL-Views<\/strong>\n<\/p>\n<p>\nTo keep up with current market trends, we take KOLs and SME&#8217;s opinion working in Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trend. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the market and the unmet needs.\n<\/p>\n<p>\n<strong>Competitive Intelligence Analysis<\/strong>\n<\/p>\n<p>\nThe publisher performs Competitive and Market Intelligence analysis of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) Market by using various Competitive Intelligence tools that include &#8211; SWOT analysis, PESTLE analysis, Porter&#8217;s five forces, BCG Matrix, Market entry strategies etc. The inclusion of the analysis entirely depends upon the data availability.\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe report covers the descriptive overview of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies\n<\/li>\n<li>\nComprehensive insight has been provided into the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) epidemiology and treatment in the 7MM\n<\/li>\n<li>\nAdditionally, an all-inclusive account of both the current and emerging therapies for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape\n<\/li>\n<li>\nA detailed review of Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market; historical and forecasted is included in the report, covering drug outreach in the 7MM\n<\/li>\n<li>\nThe report provides an edge while developing business strategies, by understanding trends shaping and driving the global Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\nIn the coming years, Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market\n<\/li>\n<li>\nThe companies and academics are working to assess challenges and seek opportunities that could influence Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) R&amp;D. The therapies under development are focused on novel approaches to treat\/improve the disease condition\n<\/li>\n<li>\nMajor players are involved in developing therapies for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD). Launch of emerging therapies will significantly impact the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market\n<\/li>\n<li>\nA better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD)\n<\/li>\n<li>\nOur in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities\n<\/li>\n<\/ul>\n<p>\n<strong>Reasons to Buy<\/strong>\n<\/p>\n<ul>\n<li>\nThe report will help in developing business strategies by understanding trends shaping and driving the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market\n<\/li>\n<li>\nTo understand the future market competition in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market and Insightful review of the key market drivers and barriers\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan\n<\/li>\n<li>\nIdentification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors\n<\/li>\n<li>\nOrganize sales and marketing efforts by identifying the best opportunities for Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market\n<\/li>\n<li>\nTo understand the future market competition in the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4855540\/systemic-sclerosis-associated-interstitial-lung?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=n7dczx&amp;utm_campaign=1718532+-+Worldwide+Systemic+Sclerosis-associated+Interstitial+Lung+Disease+Industry+to+2032+-+Insight%2C+Epidemiology+and+Market+Forecasts&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/usect2<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#x3a;&#x70;r&#101;&#x73;&#x73;&#64;&#114;&#x65;&#x73;e&#97;&#x72;&#x63;h&#97;&#110;&#x64;&#x6d;a&#114;&#x6b;&#x65;t&#115;&#x2e;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;r&#x65;s&#x65;a&#114;&#x63;&#104;&#x61;&#110;&#x64;&#109;&#x61;r&#x6b;e&#x74;s&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), historical and forecasted epidemiology as well as the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trends in the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-45490","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), historical and forecasted epidemiology as well as the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trends in the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-24T15:01:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 &#8211; Insight, Epidemiology and Market Forecasts &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-06-24T15:01:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/\"},\"wordCount\":846,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005360\\\/en\\\/1496600\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/\",\"name\":\"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005360\\\/en\\\/1496600\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-06-24T15:01:42+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005360\\\/en\\\/1496600\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220624005360\\\/en\\\/1496600\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 &#8211; Insight, Epidemiology and Market Forecasts &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) &#8211; Market Insight, Epidemiology and Market Forecast -2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This report delivers an in-depth understanding of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), historical and forecasted epidemiology as well as the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trends in the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-24T15:01:42+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 &#8211; Insight, Epidemiology and Market Forecasts &#8211; ResearchAndMarkets.com","datePublished":"2022-06-24T15:01:42+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/"},"wordCount":846,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/","name":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 - Insight, Epidemiology and Market Forecasts - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg","datePublished":"2022-06-24T15:01:42+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220624005360\/en\/1496600\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/worldwide-systemic-sclerosis-associated-interstitial-lung-disease-industry-to-2032-insight-epidemiology-and-market-forecasts-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Worldwide Systemic Sclerosis-associated Interstitial Lung Disease Industry to 2032 &#8211; Insight, Epidemiology and Market Forecasts &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=45490"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/45490\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=45490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=45490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=45490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}